Effect of Beta-Blockers on Mortality after Myocardial Infarction in Adults with COPD

Published Online: Thursday, January 16, 2014
Follow Pharmacy_Times:
Jennifer Quint, clinical lecturer in epidemiology at the London School of Hygiene and Tropical Medicine, and Liam Smeeth, professor of clinical epidemiology at the London School of Hygiene and Tropical Medicine, discuss their BMJ study of UK COPD patients who have experienced a first myocardial infarction and the impact of beta-blocker therapy on mortality.

Related Articles
Hospitalization rates for heart disease and stroke have dropped significantly over the past decade.
A recent article suggests that comparing 2 or more observations of a patient’s COPD symptoms over time can help clinicians learn why patients lose control of the disease.
Latest Issues
$auto_registration$